Institute Scientist and Senior Director of the Genomics Platform, Broad Institute of MIT and Harvard
Stacey Gabriel is Senior Director of the Genomics Platform at Broad Institute, and has led platform development, execution and operation since the Institute’s founding. She is also Chair of Professional Scientists and serves on the Institute’s Executive Leadership Team.
Gabriel is widely recognized as a leader in genomics technology and project execution. Her early work provided foundational research for the International HapMap Project. She has led the Broad Institute’s contributions to numerous flagship resource generation projects in human genetics including the HapMap, 1000 Genomes Project, The Cancer Genome Atlas (TCGA); National Heart, Lung and Blood Institute’s Exome Sequencing Project (ESP) and TOPMed program. She is Principal Investigator of the Broad Institute All of Us (AoU) Genomics Center, and serves on the AoU Program Steering Committee.
Dr. Gabriel has directed the Genomics Platform since 2012, and prior to that instantiated the first Broad Institute Platform for Genomic Analysis. Under Gabriel’s guidance, the Genomics Platform operates as one of the largest sequencing centers in the world, and continually explores, validates, optimizes, and implements new technologies, methods, and analysis tools to meet the needs of the Broad community and beyond. Gabriel and the members of her team are committed to pushing the boundaries of the genomic frontier through the application of operational excellence, advanced process design, clinical application, data analysis and technology development capabilities. She has been recognized by Clarivate Analytics as one of the most highly cited in molecular biology and genetics scientists in the world six years in a row.
Dr. Gabriel received her B.S. in molecular biology from Carnegie Mellon University and Ph.D. in human genetics from Case Western Reserve University.